The impact of anti-TNF therapy on the nonspecialist.
Brian F
BF
Mandell
D018501:Antirheumatic Agents / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D007239:Infections / Q000139:chemically induced*; D009369:Neoplasms / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D003879:Dermatologic Agents; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha